Ironwood Pharmaceuticals to Present at Cowen and Company 34th Annual Health
Cowen and Company 34th Annual Healthcare Conference
CAMBRIDGE, Mass. -- February 24, 2014
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update
at the 2014 Cowen and Company 34^th Annual Health Care Conference on Monday,
March 3, 2014 at 3:30 p.m. Eastern Time at The Boston Marriott Copley Place.
A live webcast of Ironwood’s presentation will be accessible through the
Investors section of the company’s website at www.ironwoodpharma.com. To
access the webcast, please log on to the Ironwood website approximately 15
minutes prior to the start time to ensure adequate time for any software
downloads that may be required. A replay of the webcast will be available on
Ironwood’s website for 14 days following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is focused on creating medicines that
make a difference for patients, building value to earn the continued support
of our fellow shareholders, and empowering our team to passionately pursue
excellence. We discovered, developed and are commercializing linaclotide,
which is approved in the United States and Europe. Our pipeline priorities
include exploring further opportunities for linaclotide, as well as leveraging
our therapeutic expertise in gastrointestinal disorders and our pharmacologic
expertise in guanylate cyclases to address patient needs across the upper and
lower gastrointestinal tract. Ironwood was founded in 1998 and is
headquartered in Cambridge, Mass. Connect with us at www.ironwoodpharma.com or
on Twitter at www.twitter.com/ironwoodpharma; information that may be
important to investors will be routinely posted in both these locations.
Ironwood Pharmaceuticals, Inc.
Trista Morrison, 617-374-5095
Associate Director, Corporate Communications
Meredith Kaya, 617-374-5082
Director, Investor Relations
Press spacebar to pause and continue. Press esc to stop.